forecast
Early Amyloid Clearance Could Slow Decline
Late-stage anti-amyloid drugs from Biogen and Eli Lilly slow cognitive decline by about 30 percent, and earlier treatment could reduce decline rates by 40 to 50 percent or more, potentially enabling a world without Alzheimer's.
forecastpending
Speaker
AlexEvidence Quote
“we can slow that decline by about 30%”
Source
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the BestCreated: 11/14/2026, 4:24:39 AM
Your notes
Loading notes...